Sign In
Buy BCRX
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
BioCryst to Present at Upcoming Investor Conference
11:00am, Friday, 15'th Jul 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., July 15, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the H.C. Wainwright 1st Annual Heredit
BioCryst to Present at Upcoming Investor Conference
07:00am, Friday, 15'th Jul 2022
RESEARCH TRIANGLE PARK, N.C., July 15, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the H.C. Wainwright 1st Annual Hereditar
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
01:19pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Sector ETF report for XBI
BioCryst Presents New Data Demonstrating Consistently Low Attack Rates Among HAE Patients After Switching to ORLADEYO® (berotralstat)
11:00am, Friday, 01'st Jul 2022 GlobeNewswire Inc.
—Analysis from APeX-S showed 98 percent attack-free days during treatment with ORLADEYO after switching from an injectable therapy— —Analysis from APeX-S showed 98 percent attack-free days durin
BioCryst: A Prudent Diversification
04:29pm, Friday, 24'th Jun 2022
BioCryst Pharmaceuticals shares have been clobbered due to both the bear market and the uncertainty relating to its lead developing drug (BCX9930). I believe that the FDA would remove the partial clin
Strength Seen in BioCryst (BCRX): Can Its 5.5% Jump Turn into More Strength?
12:26pm, Monday, 20'th Jun 2022 Zacks Investment Research
BioCryst (BCRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Strength Seen in BioCryst (BCRX): Can Its 5.5% Jump Turn into More Strength?
10:06am, Monday, 20'th Jun 2022
BioCryst (BCRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Why BioCryst Pharmaceuticals Topped the Market Today
09:33pm, Wednesday, 08'th Jun 2022 The Motley Fool
The company receives some good news from a top regulator.
Why BioCryst Pharmaceuticals Topped the Market Today
05:33pm, Wednesday, 08'th Jun 2022
The company receives some good news from a top regulator.
BioCryst Announces Health Canada has Authorized ORLADEYO® (berotralstat), the Only Oral Treatment for the Prevention of Hereditary Angioedema Attacks
11:00am, Monday, 06'th Jun 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., June 06, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Health Canada has approved oral, once-daily ORLADEYO® (berotralst
BioCryst to Present at Upcoming Investor Conferences
11:00am, Wednesday, 01'st Jun 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., June 01, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Jefferies Healthcare Conference in
7 Cheap Biotech Stocks to Buy Now
06:00pm, Thursday, 19'th May 2022
These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treatments in the pipelines. The post 7 Cheap Biotech Stocks to Buy Now appeared first on Inves
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
10:20am, Wednesday, 18'th May 2022 Zacks Investment Research
Smart Beta ETF report for XBI
BioCryst to Present at Upcoming Investor Conferences
11:00am, Friday, 06'th May 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., May 06, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following conferences:
BioCryst to Present at Upcoming Investor Conferences
07:00am, Friday, 06'th May 2022
RESEARCH TRIANGLE PARK, N.C., May 06, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following conferences:
